Search Result |
Top |
| Entry | Name | Description | Category | Pathway | Gene |
|---|---|---|---|---|---|
| H00014 | Non-small cell lung cancer | Lung cancer is a leading cause of cancer death among men and women in industrialized countries. Non-small-cell lung cancer (NSCLC) accounts for approximately 85% of lung cancer and represents a heterogeneous ... | Cancer | hsa05223 Non-small cell lung cancer |
EML4-ALK (translocation) [HSA:238] [KO:K05119] CD74-ROS1,SLC34A2-ROS1 (translocation) [HSA:6098] [KO:K05088] KIF5B-RET (inversion) [HSA:5979] [KO:K05126] RARB (promoter hypermethylation) [HSA:5915] [KO:K08528] RASSF1 (promoter hypermethylation) [HSA:11186] [KO:K09850] KRAS [HSA:3845] [KO:K07827] EGFR [HSA:1956] [KO:K04361] FHIT [HSA:2272] [KO:K01522] CDKN2A [HSA:1029] [KO:K06621] TP53 [HSA:7157] [KO:K04451] MET [HSA:4233] [KO:K05099] BRAF [HSA:673] [KO:K04365] PIK3CA [HSA:5290] [KO:K00922] IRF1 [HSA:3659] [KO:K09444] PPP2R1B [HSA:5519] [KO:K03456] |
| H02525 | Disorders of innate immunity | Innate immune responses represent the first line of defense against potentially invading organisms. Disorders of innate immunity (e.g. phagocyte and complement disorders) delay the induction of the immune ... | Immune system disease |
(IMD44) STAT2 [HSA:6773] [KO:K11221] (IMD45) IFNAR2 [HSA:3455] [KO:K05131] (IMD57) RIPK1 [HSA:8737] [KO:K02861] (IMD63) IL2RB [HSA:3560] [KO:K05069] (IMD65) IRF9 [HSA:10379] [KO:K04693] (IMD77) MPEG1 [HSA:219972] [KO:K26547] (IMD80) MCM10 [HSA:55388] [KO:K10736] (IMD90) FADD [HSA:8772] [KO:K02373] (IMD91) ZNFX1 [HSA:57169] [KO:K27391] (IMD95) IFIH1 [HSA:64135] [KO:K12647] (IMD106) IFNAR1 [HSA:3454] [KO:K05130] (IMD115) RNF31 [HSA:55072] [KO:K11974] (IMD117) IRF1 [HSA:3659] [KO:K09444] |
| [ KEGG | DISEASE | DRUG | MEDICUS ] |